Marianne Langston

Title: Innovations by Marianne Langston in Pharmaceutical Sciences

Introduction

Marianne Langston, an innovative inventor based in North Andover, MA, has made significant contributions to the field of pharmaceutical sciences. With an impressive portfolio of 10 patents, her work primarily focuses on the development of novel pharmaceutical compounds aimed at treating critical medical disorders.

Latest Patents

One of her latest patents involves "Pharmaceutical salts of pyrimidine derivatives and method of treating disorders.” This disclosure describes pharmaceutical salts and polymorphic forms of pyrimidine derivatives that exhibit inhibitory activities against mutant epidermal growth factor receptor (EGFR). The patent also details the processes for preparing these pyrimidine derivatives, including the pharmaceutical salts and polymorphic forms.

Another notable patent is for "Crystalline forms of 2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one hemihydrate." This disclosure relates to the crystalline forms of the compound, along with processes for preparing these forms. Additionally, it covers pharmaceutical compositions including the crystalline forms and methods for treating cell division cycle 7 mediated cancer in mammals.

Career Highlights

Marianne has had a diverse career in the pharmaceutical industry, working for prestigious companies like Millennium Pharmaceuticals Limited and Takeda Pharmaceutical Company Limited. Her roles in these organizations have allowed her to pioneer research and development in innovative pharmaceutical solutions.

Collaborations

Throughout her career, Marianne has collaborated with esteemed colleagues such as Ian G. Armitage and Steven P. Langston. These partnerships have been instrumental in advancing her research and expanding the scope of her innovative work.

Conclusion

Marianne Langston stands out as a prolific inventor whose patents reflect her dedication to enhancing healthcare through innovative pharmaceutical solutions. Her contributions not only represent significant advancements in the field but also demonstrate the importance of collaboration in driving scientific progress. As she continues to develop new compounds, her work promises to make a lasting impact on the treatment of crucial medical conditions.